Skip to content
10-Q

Quarterly Report

HELIX BIOMEDIX INC

0001437749-11-005453

← back to feed
Filed
Aug 4, 2011 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2011 · Aug 1, 2011 49.72M sh
Stockholders Equity Q2 2011 · Jun 30, 2011 $3.66M
Stockholders Equity Q2 2011 · Dec 31, 2009 −$5.17M
Current Liabilities Q2 2011 · Jun 30, 2011 $368.4K
Current Liabilities Q2 2011 · Dec 31, 2010 $318.22K
Total Liabilities Q2 2011 · Jun 30, 2011 $401.32K
Total Liabilities Q2 2011 · Dec 31, 2010 $354.04K
Current Assets Q2 2011 · Jun 30, 2011 $3.61M
Current Assets Q2 2011 · Dec 31, 2010 $4.67M
Total Assets Q2 2011 · Jun 30, 2011 $4.06M
Total Assets Q2 2011 · Dec 31, 2010 $5.23M
Net Income Q2 2011 · Dec 31, 2010 −$7.71M
Net Income Q2 2011 · Jun 30, 2010 −$942.49K
Net Income Q2 2011 · Jun 30, 2010 −$1.87M
Shares Diluted Q2 2011 · Jun 30, 2010 25.65M sh
Shares Diluted Q2 2011 · Jun 30, 2010 25.65M sh
Capex Q2 2011 · Jun 30, 2010 $1.21K
Operating Cash Flow Q2 2011 · Jun 30, 2010 −$1.51M
Cash And Equivalents Q2 2011 · Jun 30, 2010 $3.04M
Cash And Equivalents Q2 2011 · Dec 31, 2009 $1.34M
Eps Diluted Q2 2011 · Jun 30, 2010 −$0.04
Eps Diluted Q2 2011 · Jun 30, 2010 −$0.07
Sga Expense Q2 2011 · Jun 30, 2010 $347.12K
Sga Expense Q2 2011 · Jun 30, 2010 $706.86K
Rd Expense Q2 2011 · Jun 30, 2010 $208.19K
Rd Expense Q2 2011 · Jun 30, 2010 $375.87K
Operating Income Q2 2011 · Jun 30, 2010 −$724.87K
Operating Income Q2 2011 · Jun 30, 2010 −$1.48M
Gross Profit Q2 2011 · Jun 30, 2010 $205.65K
Gross Profit Q2 2011 · Jun 30, 2010 $250.88K
Cost Of Revenue Q2 2011 · Jun 30, 2010 $124.75K
Cost Of Revenue Q2 2011 · Jun 30, 2010 $149.23K
Revenue Q2 2011 · Jun 30, 2010 $330.4K
Revenue Q2 2011 · Jun 30, 2010 $400.12K